Hemodynamic and renal effects of bosentan and losartan in 2k1c hypertensive rats.

Sarkawt Hamad and Ismail Maulood
Biology Department, Faculty of Science, Soran University, Soran, Iraq;
Biology Department, College of Science, Salahaddin University, Erbil, Iraq


Abstract 

Endothelin-1 (ET-1) and Angiotensin II (Ang II) play important roles in generating
hypertension. The present work was investigated the hemodynamic and renal effects of
both ET-1 and Ang II on 2K1C rats. The design of this study included five groups of rats:
Group 1 Sham rats, Group 2 Normotensive rats (2K1C(n)), Group 3 two kidney one clip
hypertensive rats (2K1C(h)), Group 4 two kidney one clip hypertensive rats + Bosentan
(2K1C(h) + Bosentan), and Group 5 two kidney one clip hypertensive rats + Losartan
(2K1C(h) + Losartan). Systolic blood pressure (SBP) was significantly elevated in 2K1C(h)
rats from third to sixth week after surgery compared with control rats. SBP significantly
fell in bosentan and losartan treated rats. Serum nitric oxide (NO) level in hypertensive
rats was slightly decreased, whereas in losartan group it was significantly increased.
Serum malonaldehyde (MDA) significantly increased in bosentan treated rats as
compared to hypertensive rats. Bosentan administration caused a markedly increased in
Na+excretion rate compared with 2K1C(h) rats in week four after surgery. In conclusion,
losartan is more potent than bosentan in reducing hypertension via elevation of serum
NO level.


Key Words:
2K1C Goldblatt mode,
Systolic blood pressure
Bosentan
Losartan


References

1. Baydal, D.K., Lata, H. and Dadhich, A.P. ''ANIMAL MODELS OF HYPERTENSION AND EFFECT OF DRUGS'', Indian Journal of Pharmacology, Vol. (35), pp. 349-62. (2003).

2. Chabielska, E., Matys, T., Kucharewicz, I., Pawlak, D., Rolkowski, R. and Buczko, W. "The 
involvement of AT(2)-receptor in the antithrombotic effect of losartan in renal hypertensive rats", J Renin Angiotensin Aldosterone Syst, Vol. (1), No. (3), pp. 263-7. (2000).

3. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., and Mitsui, Y. "A novel potent 
vasoconstrictor peptide produced by vascular endothelial cells", Nature, Vol. (332), No. (6163), pp. 411-5. (1988).

4. Dhaun, N., Goddard, J., Kohan, D.E., Pollock, D.M., Schiffrin, E.L. and Webb, D.J. "Role of 
endothelin-1 in clinical hypertension: 20 years on", Hypertension, Vol. (52) No. (3), pp. 452-9. (2008).

5. Schiffrin, E.L., Lariviere, R., Li, J.S., Sventek, P. and Touyz, R.M. "Deoxycorticosterone acetate plus 
salt induces overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats", Hypertension, Vol. (25), No. (4 Pt 2), pp. 769-73. (1995).

6. Davenport, A.P. and Battistini, B. "Classification of endothelin receptors and antagonists in clinical 
development", Clin Sci, Vol. (103), No. (48), pp. 1S-3S. (2002).

7. Gilliam-Davis, S., Gallagher, P.E., Payne, V.S., Kasper, S.O., Tommasi, E.N. and Westwood, B.M. 
"Long-term systemic angiotensin II type 1 receptor blockade regulates mRNA expression of dorsomedial medulla renin-angiotensin system components", Physiol Genomics, Vol. (43) No. (13), pp. 829-35. (2011).

8. Barrett, K.E., Barman, S.M. and Boitano, S. "Ganong’s review of medical physiology", Brooks 
HLTteM-H, United States of America. (2010).

9. Cotter, J.L., Vandongen, R. and Burton. D.L. "Sturm MJ. Platelet activating factor and one-kidney, 
one clip hypertension", Hypertension, Vol. (15) No. (6 Pt 1), pp 628-32. (1990).

10. Lee, T.M., Lin, M.S. and Chang, N.C. "Physiological concentration of 17beta-estradiol on 
sympathetic reinnervation in ovariectomized infarcted rats", Endocrinology, Vol. (149) No. (3), pp. 1205-13. (2008).

11. Thone-Reineke, C., Olivier, J., Godes, M., Zart, R., George, I. and Bauer, C. "Effects of angiotensin- converting enzyme inhibition and calcium channel blockade on cardiac apoptosis in rats with 2K1C (two- kidney/one-clip) renovascular hypertension", Clin Sci, Vol. (104) No. (1), pp. 79-85. (2003).

12. De Nicola, L., Blantz, R.C. and Gabbai, F.B. "Nitric oxide and angiotensin II. Glomerular and tubular interaction in the rat". J Clin Invest, Vol. (89), No. (4), pp. 1248-56. (1992).

13. Huskic, J., Culo, F., Dautovic, S. and Mulabegovic, N." Angiotensin converting enzyme activity and nitric oxide level in serum patients with dehydration", Bosn J Basic Med Sci, Vol. (7), No. (1), pp. 33-6. (2007).

14. Xiong, Y., Fu, Y.F., Fu, S.H. and Zhou, H.H. "Elevated levels of the serum endogenous inhibitor of 
nitric oxide synthase and metabolic control in rats with streptozotocin-induced diabetes", J Cardiovasc Pharmacol, Vol. (42) No. (2), pp. 191-6. (2003).

15. Helle, F., Vagnes, O.B, and Iversen, B.M. "Angiotensin II-induced calcium signaling in the afferent 
arteriole from rats with two-kidney, one-clip hypertension" Am J Physiol Renal Physiol, Vol. (291), No. (1), pp.7. (2006).

16. Bedard, K. and Krause, K.H. "The NOX family of ROS-generating NADPH oxidases: physiology and 
pathophysiology", Physiol Rev, Vol. (87), No. (1), pp. 245-313. (2007).

17. Yan, C., Kim, D., Aizawa, T. and Berk, B.C. "Functional interplay between angiotensin II and nitric 
oxide: cyclic GMP as a key mediator" Arterioscler Thromb Vasc Biol, Vol. (23), No. (1), pp. 26-36. (2003).

18. Pinto, Y.M., Paul, M. and Ganten, D. "Lessons from rat models of hypertension: from Goldblatt to 
genetic engineering", Cardiovasc Res, Vol. (39), No. (1), pp. 77-88. (1998).

19. Melaragno, M.G. and Fink, G.D. "Slow pressor effect of angiotensin II in normotensive rats with renal 
artery stenosis", Clin Exp Pharmacol Physiol, Vol. (23), No. (2), pp.140-4. (1996).

20. Benz, J., Oshrain, C., Henry, D., Avery, C., Chiang, Y.T. and Gatlin, M. "Valsartan, a new angiotensin 
II receptor antagonist: a double-blind study comparing the incidence of cough with lisinopril and hydrochlorothiazide", J Clin Pharmacol, Vol. (37), No. (2), pp. 101-7. (1997).

21. Eriksson, C., Gustavsson, A., Kronvall, T. and Tysk, C. "Hepatotoxicity by bosentan in a patient with 
portopulmonary hypertension: a case-report and review of the literature" J Gastrointestin Liver Dis, Vol. (20), No. (1), pp.77-80. (2011).

22. Rich, S. and McLaughlin, V.V. "Endothelin receptor blockers in cardiovascular disease" Circulation, 
Vol. (108), No.(18), pp. 2184-90. (2003).

23. Liu, J., Gong, H., Zhang, Z.T. and Wang Y. "Effect of angiotensin II and angiotensin II type 1 receptor 
antagonist on the proliferation, contraction and collagen synthesis in rat hepatic stellate cells", Chin Med J, Vol. (121) No. (2), pp.161-5. (2008).

24. Warner, F.J., Lubel, J.S., McCaughan, G.W. and Angus, P.W. "Liver fibrosis: a balance of ACEs?" 
Clin Sci, Vol. (113). No. (3), pp 109-18. (2007).

25. Abdulazeez, A.M., C.A. Awasum, Dogo, Y.S. and Abiayi, P.N. "Effect of Peristrophe bicalyculata on 
Blood Pressure, Kidney and Liver Functions of Two Kidney One Clip (2K1C) Hypertensive Rats" , British Journal of Pharmacology and Toxicology, Vol. (1), No. (2), pp.101-7. (2010).

26. Sookoian, S., Fernandez, M.A. and Castano, G. "Effects of six months losartan administration on liver 
fibrosis in chronic hepatitis C patients: a pilot study", World J Gastroenterol, Vol. (11), No.(48), pp. 7560-3. (2005).